PROK

ProKidney Corp. is an innovative biotechnology company headquartered in Winston-Salem, North Carolina, specializing in transformative solutions for chronic kidney disease (CKD). The firm is pioneering cell-based therapies aimed at restoring kidney function and improving the quality of life for patients afflicted by this widespread ailment. With a robust pipeline of development initiatives and a commitment to advancing renal health, ProKidney is strategically positioned in the biopharmaceutical sector, making it an attractive opportunity for institutional investors seeking to drive meaningful healthcare advancements.